Brief: PYC Therapeutics Says HY Revenues From Ordinary Activities Up 162% To A$9.1 Million
Feb 29 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* HY REVENUES FROM ORDINARY ACTIVITIES UP 162% TO A$9.1
MILLION
* HY LOSS ATTRIBUTABLE A$15.1 MILLION VERSUS LOSS OF A$16.2
MILLION
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director